当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析 - 利润表

益佰制药

(600594)

  

流通市值:45.77亿  总市值:45.77亿
流通股本:7.92亿   总股本:7.92亿

利润表

按照会计年度查询:
报告期2020-03-312019-12-312019-06-302019-03-31
一、营业总收入687,398,859.163,361,025,745.291,608,882,256.8824,625,331.83
营业收入687,398,859.163,361,025,745.291,608,882,256.8824,625,331.83
二、营业总成本620,408,078.653,096,386,873.261,499,637,353.74750,768,138.24
营业成本150,180,172.05735,601,505.67392,353,432.86193,018,473.32
营业税金及附加11,008,960.3141,824,454.3720,920,310.15--
销售费用383,340,840.911,788,970,864.18834,794,701.92441,385,558.33
管理费用68,487,752.19366,411,486.25161,605,872.0582,342,710.05
财务费用-1,739,207.2245,029,689.3416,979,433.01612,384.28
资产减值损失-4,986.07-106,166,162.230,462,023.17-20,766.53
三、其他经营收益-310,581.6-2,303,019.83-1,199,528.09365,813.23
允许价值变动净收益--------
投资净收益-151,850.9671,850,878.36-408,184.04-51,875.7
联营、合营企业投资收益---187,815.87----
汇兑净收益--------
四、营业利润72,733,548.59238,752,799.78126,649,158.3578,394,468.72
营业外收入441,301.392,928,232.4542,438.93-292,668.15
营业外支出4,313,997.7233,358,382.373,325,392.223,190,505.87
非流动资产处置净损失--------
五、利润总额68,860,852.26208,322,649.86123,366,205.0674,911,294.7
所得税14,126,470.5875,905,553.0730,141,386.7820,831,054.27
未确认的投资损失--------
六、净利润(百万元)59.84141.9156.6102.21
少数股东损益-5,103,779.63-9,478,101.9-8,986,644.05-5,150,557.8
归属于母公司股东的净利润59,838,161.31141,895,198.69102,211,462.3359,230,798.23
七、每股收益0.080.180.13--
基本每股收益0.080.180.130.08
稀释每股收益0.080.180.130.08
TOP↑